Skip to main content
Carl Koschmann, MD, Pediatric Hematology & Oncology, Ann Arbor, MI

Carl Koschmann MD

Pediatric Neuro-Oncology


Associate Professor

Join to View Full Profile
  • 1500 E Medical Center DrAnn Arbor, MI 48109

  • Phone+1 734-936-4000

Dr. Koschmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • The Koschmann Lab

    The Koschmann lab is studying the molecular mechanisms by which mutations in pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) can be ther

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemPost-Doctoral Fellowship, Pediatric Neuro-Oncology, 2014 - 2015
  • University of Michigan
    University of MichiganFellowship, Pediatric Hematology/Oncology, 2011 - 2014
  • University of Washington
    University of WashingtonResidency, Pediatrics, 2007 - 2010
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 2007

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2027
  • WA State Medical License
    WA State Medical License 2007 - 2016
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘Beating the Odds’: Hope for U-M Drummer with Inoperable Brain Tumor
    ‘Beating the Odds’: Hope for U-M Drummer with Inoperable Brain TumorMarch 31st, 2025
  • Repurposed Drug Treats Aggressive Pediatric Brain Tumor
    Repurposed Drug Treats Aggressive Pediatric Brain TumorMarch 18th, 2025
  • Repurposed Cancer Drug Demonstrates Potential to Treat High-Grade Gliomas
    Repurposed Cancer Drug Demonstrates Potential to Treat High-Grade GliomasMarch 14th, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: